Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of BH.IMMUN&BIO. For more details, see the BH.IMMUN&BIO quarterly results and BH.IMMUN&BIO share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -2.2 |
No. of shares | m | 43.18 |
1 Week | % | 6.1 |
1 Month | % | 6.2 |
1 Year | % | 34.3 |
52 week H/L | Rs | 43.9/20.5 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
BH.IMMUN&BIO EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 27 | 15 | 88 | 95 | 52 | |
Low | Rs | 7 | 5 | 6 | 28 | 21 | |
Sales per share (Unadj.) | Rs | 19.4 | 15.5 | 19.8 | 18.2 | 10.3 | |
Earnings per share (Unadj.) | Rs | -1.3 | -2.4 | -4.2 | -2.0 | -3.9 | |
Diluted earnings per share | Rs | -1.3 | -2.4 | -4.2 | -2.0 | -3.9 | |
Cash flow per share (Unadj.) | Rs | -1.3 | -2.3 | -4.1 | -2.0 | -3.8 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 7.1 | 4.7 | 7.9 | 24.4 | 20.4 | |
Adj. book value per share | Rs | 7.1 | 4.7 | 7.9 | 24.4 | 20.4 | |
Shares outstanding (eoy) | m | 43.18 | 43.18 | 43.18 | 43.18 | 43.18 | |
Price / Sales ratio | x | 0.9 | 0.7 | 2.4 | 3.4 | 3.5 | |
Avg P/E ratio | x | -12.8 | -4.3 | -11.1 | -30.2 | -9.4 | |
P/CF ratio (eoy) | x | -13.4 | -4.4 | -11.3 | -31.0 | -9.5 | |
Price / Book Value ratio | x | 2.4 | 2.1 | 5.9 | 2.5 | 1.8 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 739 | 436 | 2,011 | 2,645 | 1,561 | |
Total wages/salary | Rs m | 98 | 114 | 144 | 138 | 151 |
BH.IMMUN&BIO INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 836 | 668 | 853 | 784 | 446 | |
Other income | Rs m | 42 | 12 | 17 | 11 | 11 | |
Total revenues | Rs m | 879 | 680 | 870 | 795 | 457 | |
Gross profit | Rs m | -93 | -104 | -209 | -50 | -161 | |
Depreciation | Rs m | 3 | 2 | 2 | 2 | 2 | |
Interest | Rs m | 20 | 48 | 48 | 56 | 71 | |
Profit before tax | Rs m | -74 | -142 | -242 | -97 | -223 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -16 | -40 | -61 | -9 | -56 | |
Profit after tax | Rs m | -58 | -102 | -181 | -88 | -166 | |
Gross profit margin | % | -11.1 | -15.6 | -24.4 | -6.3 | -36.0 | |
Effective tax rate | % | 21.4 | 28.1 | 25.2 | 9.6 | 25.3 | |
Net profit margin | % | -6.9 | -15.3 | -21.2 | -11.2 | -37.3 |
BH.IMMUN&BIO BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 987 | 930 | 340 | 654 | 358 | |
Current liabilities | Rs m | 885 | 1,007 | 641 | 1,013 | 940 | |
Net working cap to sales | % | 12.3 | -11.5 | -35.3 | -45.7 | -130.6 | |
Current ratio | x | 1.1 | 0.9 | 0.5 | 0.6 | 0.4 | |
Inventory Days | Days | 49 | 83 | 59 | 48 | 85 | |
Debtors Days | Days | 3,184 | 962 | 0 | 53 | 1,135 | |
Net fixed assets | Rs m | 162 | 198 | 499 | 1,263 | 1,262 | |
Share capital | Rs m | 432 | 432 | 432 | 432 | 432 | |
"Free" reserves | Rs m | -125 | -227 | -91 | 622 | 450 | |
Net worth | Rs m | 307 | 205 | 340 | 1,054 | 882 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 1,150 | 1,128 | 839 | 1,917 | 1,620 | |
Interest coverage | x | -2.7 | -2.0 | -4.1 | -0.7 | -2.2 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.7 | 0.6 | 1.0 | 0.4 | 0.3 | |
Return on assets | % | -3.3 | -4.8 | -15.9 | -1.6 | -5.9 | |
Return on equity | % | -18.9 | -49.9 | -53.2 | -8.3 | -18.9 | |
Return on capital | % | -17.5 | -46.2 | -57.0 | -3.9 | -17.2 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 105.2 | 142.3 | 57.7 | 108.4 | 14.5 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 880 | 951 | 492 | 850 | 65 | |
Fx inflow | Rs m | 33 | 1 | 4 | 0 | 0 | |
Fx outflow | Rs m | 880 | 951 | 492 | 850 | 65 | |
Net fx | Rs m | -848 | -950 | -488 | -850 | -65 |
BH.IMMUN&BIO CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -321 | 341 | 118 | -421 | 109 | |
From Investments | Rs m | 7 | 9 | 7 | 5 | 5 | |
From Financial Activity | Rs m | 306 | -344 | -122 | 450 | -147 | |
Net Cashflow | Rs m | -8 | 6 | 2 | 34 | -34 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Sudhanshu Vrati | COMP SEC: Sandip Kumar Lal | YEAR OF INC: 1989 | BSE CODE: 524663 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare BH.IMMUN&BIO With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.